Pulmatrix, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for PULM, updated each market day.
PULM AI Sentiment
AI sees no strong directional signal for Pulmatrix, Inc. Common Stock stock over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Pulmatrix, Inc. Common Stock
Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
Sector
Exchange
Market Cap
$5,233,359
Cap Tier
Employees
2
Headquarters
FRAMINGHAM, MA
Listed Since
March 21, 2014
Website
PULM Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PULM Volatility
Pulmatrix, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
